These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8738765)

  • 1. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring.
    Nicolau DP; Wu AH; Finocchiaro S; Udeh E; Chow MS; Quintiliani R; Nightingale CH
    Ther Drug Monit; 1996 Jun; 18(3):263-6. PubMed ID: 8738765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic impact of once-daily aminoglycoside administration.
    Hitt CM; Klepser ME; Nightingale CH; Quintiliani R; Nicolau DP
    Pharmacotherapy; 1997; 17(4):810-4. PubMed ID: 9250562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of once-daily gentamicin dosing in pediatric patients.
    Bass KD; Larkin SE; Paap C; Haase GM
    J Pediatr Surg; 1998 Jul; 33(7):1104-7. PubMed ID: 9694103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of once-daily versus conventional administration of gentamicin and tobramycin.
    Mithani H; Brown G
    Pharmacoeconomics; 1996 Nov; 10(5):494-503. PubMed ID: 10163631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily versus pharmacokinetic dosing of aminoglycosides.
    Medicus-Bringa M; Ward G; Rice M
    Am J Med; 1997 Oct; 103(4):328-30. PubMed ID: 9382126
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Relationship between FEV
    Hoff BM; Scheetz MH; Jain M; Cullina JF; Rhodes NJ
    Pharmacotherapy; 2020 Jun; 40(6):584-591. PubMed ID: 32259317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates.
    Valitalo PA; van den Anker JN; Allegaert K; de Cock RF; de Hoog M; Simons SH; Mouton JW; Knibbe CA
    J Antimicrob Chemother; 2015 Jul; 70(7):2074-7. PubMed ID: 25766737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods.
    Franson TR; Quebbeman EJ; Whipple J; Thomson R; Bubrick J; Rosenberger SL; Ausman RK
    Crit Care Med; 1988 Sep; 16(9):840-3. PubMed ID: 3402229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
    Hoffa DE
    Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performance of gentamicin dosing nomograms.
    Lee J; Yoon S; Shin D; Han H; An H; Lee J; Lim KS; Yu KS; Lee H
    Drug Des Devel Ther; 2014; 8():1097-106. PubMed ID: 25152616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.